Allison L Bayer

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells
    Allison L Bayer
    Department of Microbiology and Immunology, Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Immunol 181:225-34. 2008
  2. ncbi Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells
    Allison L Bayer
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, 1600 Northwest 10th Avenue, Miami, FL 33136, USA
    J Immunol 178:4062-71. 2007
  3. ncbi IL-2 family of cytokines in T regulatory cell development and homeostasis
    Thomas R Malek
    Department of Microbiology and Immunology, University of Miami, RMSB 3119, Miami, FL, USA
    J Clin Immunol 28:635-9. 2008
  4. ncbi Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period
    Allison L Bayer
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Exp Med 201:769-77. 2005
  5. ncbi Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance
    Dennis Adeegbe
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, FL 33101, USA
    J Immunol 176:7149-53. 2006
  6. ncbi Quantitative assessment concerning the contribution of IL-2Rbeta for superantigen-mediated T cell responses in vivo
    Haoli Jin
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, PO Box 016960, Miami, FL 33101, USA
    Int Immunol 18:565-72. 2006
  7. ncbi Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT
    Allison L Bayer
    Department of Microbiology Immunology, Miller School of Medicine, University of Miami, FL 33101, USA
    Blood 113:733-43. 2009
  8. ncbi Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy
    Gaetano Faleo
    Diabetes Research Institute, Cell Transplant Center, University ofMiami, Miami, Florida, USA
    Diabetes 61:1769-78. 2012
  9. ncbi Tolerance, not immunity, crucially depends on IL-2
    Thomas R Malek
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida 33136, USA
    Nat Rev Immunol 4:665-74. 2004

Collaborators

Detail Information

Publications9

  1. ncbi A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells
    Allison L Bayer
    Department of Microbiology and Immunology, Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Immunol 181:225-34. 2008
    ..Collectively, these data indicate that IL-7R signaling contributes to Treg cell development and peripheral homeostasis...
  2. ncbi Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells
    Allison L Bayer
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, 1600 Northwest 10th Avenue, Miami, FL 33136, USA
    J Immunol 178:4062-71. 2007
    ..Collectively, these data support the notion that normally IL-2 is a dominant mechanism controlling the number of thymic and peripheral T(reg) cells...
  3. ncbi IL-2 family of cytokines in T regulatory cell development and homeostasis
    Thomas R Malek
    Department of Microbiology and Immunology, University of Miami, RMSB 3119, Miami, FL, USA
    J Clin Immunol 28:635-9. 2008
    ..Interleukin 2 (IL-2) induces an essential signal for T regulatory (Treg) cells. Without a functional IL-2R, only immature CD4(+) Foxp3(low) CD25(neg) T cells develop, and these cells fail to suppress autoreactive T cells in the periphery...
  4. ncbi Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period
    Allison L Bayer
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Exp Med 201:769-77. 2005
    ..However, for normal neonates, blockade of IL-2 decreased T(reg) cells in both the thymus and LN. Therefore, two steps of T(reg) cell development depend upon IL-2 in neonatal mice, thymus production, and subsequent expansion in the LN...
  5. ncbi Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance
    Dennis Adeegbe
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, FL 33101, USA
    J Immunol 176:7149-53. 2006
    ..Collectively, these data demonstrate that effective engraftment by allogeneic Treg cells controls autoimmunity and results in permissive conditions for long-term acceptance of allografts...
  6. ncbi Quantitative assessment concerning the contribution of IL-2Rbeta for superantigen-mediated T cell responses in vivo
    Haoli Jin
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, PO Box 016960, Miami, FL 33101, USA
    Int Immunol 18:565-72. 2006
    ....
  7. ncbi Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT
    Allison L Bayer
    Department of Microbiology Immunology, Miller School of Medicine, University of Miami, FL 33101, USA
    Blood 113:733-43. 2009
    ....
  8. ncbi Prevention of autoimmune diabetes and induction of β-cell proliferation in NOD mice by hyperbaric oxygen therapy
    Gaetano Faleo
    Diabetes Research Institute, Cell Transplant Center, University ofMiami, Miami, Florida, USA
    Diabetes 61:1769-78. 2012
    ..The safety profile and noninvasiveness makes HOT an appealing adjuvant therapy for diabetes prevention and intervention trials...
  9. ncbi Tolerance, not immunity, crucially depends on IL-2
    Thomas R Malek
    Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida 33136, USA
    Nat Rev Immunol 4:665-74. 2004
    ..Here, we discuss these findings and, in particular, the action of IL-2 on regulatory T cells and effector cells, and the targeting of IL-2 and/or the IL-2 receptor in clinical settings...